Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,857 · see citing works

Molecular Basis of Colorectal Cancer

Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052 · see citing works

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan‐Smith, E., Dalton, J., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,798 · see citing works

Regulation of translation initiation by FRAP/mTOR

Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545 · see citing works

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · see citing works

Acute Lymphoblastic Leukemia

Pui, C., Relling, M. V., & Downing, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra023001 · Cited by 1,182 · see citing works

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818 · see citing works

CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

Firestein, R., Bass, A., Kim, S., Dunn, I., Silver, S., Guney, I., Freed, E., Ligon, A., Vena, N., Ogino, S., et al. (2008) · Nature · doi:10.1038/nature07179 · Cited by 715 · see citing works

The role of DNA mismatch repair in platinum drug resistance.

Fink, D. A., Nebel, S., Aebi, S. P., Zheng, H., Cenni, B., Nehmé, A., Christen, R. D., & Howell, S. B. (1996) · PubMed · Cited by 597 · see citing works

TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.Preprint

Gao, X., & Pan, D. (2001) · Genes & Development · doi:10.1101/gad.901101 · Cited by 484 · see citing works

Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer

Karran, P., & Attard, N. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2292 · Cited by 477 · see citing works

Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of Thioguanine

SWANN, P. F., Waters, T. R., Moulton, D. C., Xu, Y., Zheng, Q., Edwards, M., & Mace, R. (1996) · Science · doi:10.1126/science.273.5278.1109 · Cited by 409 · see citing works

Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage

Branch, P., Aquilina, G., Bignami, M., & Karran, P. (1993) · Nature · doi:10.1038/362652a0 · Cited by 361 · see citing works

Modulation of mismatch repair and genomic stability by miR-155

Valeri, N., Gasparini, P., Fabbri, M., Braconi, C., Veronese, A., Lovat, F., Adair, B., Vannini, I., Fanini, F., Bottoni, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002472107 · Cited by 347 · see citing works

TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase

Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., & Guan, K.-L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500451200 · Cited by 234 · see citing works

Mismatch repair deficiency associated with overexpression of the MSH3 gene

Marra, G., Iaccarino, I., Lettieri, T., Roscilli, G., Delmastro, P., & Jiricny, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8568 · Cited by 208 · see citing works

Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management

Lynch, H. T., Casey, M. J., Snyder, C., Bewtra, C., Lynch, J. F., Butts, M., & Godwin, A. K. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.02.004 · Cited by 205 · see citing works

Protein phosphatase 2A is a critical regulator of protein kinase C ζ signaling targeted by SV40 small t to promote cell growth and NF‐κB activation

Sontag, E., Sontag, J., & Garcı́a, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5662 · Cited by 191 · see citing works

Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation

DeWeese, T. L., Shipman, J. M., Larrier, N., Buckley, N. M., Kidd, L. R., Groopman, J. D., Cutler, R. G., Riele, H. T., & Nelson, W. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11915 · Cited by 188 · see citing works

Functional interactions and signaling properties of mammalian DNA mismatch repair proteins

Bellacosa, A. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400948 · Cited by 188 · see citing works

Mouse models for hereditary nonpolyposis colorectal cancer.

de Wind, N., Dekker, M., van Rossum, A. G. J., van der Valk, M., & Riele, H. T. (1998) · PubMed · Cited by 162 · see citing works

Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers

Kuismanen, S. A., Holmberg, M. T., Salovaara, R., Schweizer, P., Aaltonen, L. A., de la Chapelle, A., Nyström, M., & Peltomäki, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12661 · Cited by 127 · see citing works

Microsatellite Instability and p53 Mutations Are Associated With Abnormal Expression of the MSH2 Gene in Adult Acute Leukemia

Zhu, Y.-M., Das-Gupta, E. P., & Russell, N. H. (1999) · Blood · doi:10.1182/blood.v94.2.733 · Cited by 118 · see citing works

Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease

Paulsson, K. M., Cazier, J., MacDougall, F., Stevens, J. M., Stasevich, I., Vrcelj, N., Chaplin, T., Lillington, D. M., Lister, T. A., & Young, B. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800408105 · Cited by 112 · see citing works

Role of class II phosphoinositide 3-kinase in cell signalling

Falasca, M., & Maffucci, T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350211 · Cited by 111 · see citing works

Constitutive deficiency in DNA mismatch repair

Felton, K., Gilchrist, D., & Andrew, S. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00803.x · Cited by 109 · see citing works

Inherited Susceptibility to Colorectal Cancer

Rowley, P. T. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.061704.135235 · Cited by 88 · see citing works

Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers

Yuen, S. T., Chan, T. L., Ho, J. W. C., Chan, A. S. Y., Chung, L.-P., Lam, P. W., Tse, C. W., Wyllie, A. H., & Leung, S. Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205968 · Cited by 76 · see citing works

Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents

Dösch, J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.4.567 · Cited by 50 · see citing works

Degadration of mismatch repair hMutSα heterodimer by the ubiquitin‐proteasome pathway

Hernandez-Pigeon, H., Laurent, G., Humbert, O., Salles, B., & Lautier, D. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00181-4 · Cited by 33 · see citing works

hMutSα is Protected from Ubiquitin-proteasome-dependent Degradation by Atypical Protein Kinase Cζ Phosphorylation

Hernandez-Pigeon, H., Quillet‐Mary, A., Louat, T., Schambourg, A., Humbert, O., Sèlves, J., Salles, B., Laurent, G., & Lautier, D. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.001 · Cited by 33 · see citing works

Induction of Two DNA Mismatch Repair Proteins, MSH2 and MSH6, in Differentiated Human Neuroblastoma SH‐SY5Y Cells

Belloni, M., Uberti, D. L., Rizzini, C., Jiricny, J., & Memo, M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720974.x · Cited by 24 · see citing works

Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis

Bouffler, S. D., Hofland, N., Cox, R., & Fodde, R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1422 · Cited by 16 · see citing works

Expression of DNA Mismatch Repair Proteins in Acute Lymphoblastic Leukaemia and Normal Bone Marrow

Matheson, E. C., & Hall, A. G. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_64 · Cited by 16 · see citing works

DNA repair alterations in common pediatric malignancies.

Papaefthymiou, M. A., Giaginis, C. T., & Theocharis, S. E. (2008) · PubMed · Cited by 14 · see citing works

Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-- Mice

Krynetskaia, N. F., Brenner, T. L., Krynetski, E. Y., Du, W., Panetta, J. C., Pui, C., & Evans, W. E. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.456 · Cited by 12 · see citing works

Next-generation characterization of the Cancer Cell Line Encyclopedia

Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394 · see citing works

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3860 · Cited by 1,365 · see citing works

Acute lymphoblastic leukaemia

Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074 · see citing works

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Pui, C., Yang, J. J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A. J., Baruchel, A., Silverman, L. B., Schmiegelow, K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1636 · Cited by 1,016 · see citing works

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

Moriyama, T., Nishii, R., Pérez-Andreu, V., Yang, W., Antillón‐Klussmann, F., Zhao, X., Lin, T.-N., Hoshitsuki, K., Nersting, J., Kihira, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3508 · Cited by 478 · see citing works

Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors

Mensenkamp, A. R., Vogelaar, I. P., van Zelst–Stams, W. A. G., Goossens, M., Ouchene, H., Hendriks-Cornelissen, S. J. B., Kwint, M. P., Hoogerbrugge, N., Nagtegaal, I. D., & Ligtenberg, M. J. L. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.12.002 · Cited by 329 · see citing works

Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance

Wilting, R. H., & Dannenberg, J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.008 · Cited by 302 · see citing works

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

Meyer, J. A., Wang, J., Hogan, L. E., Yang, J. J. J., Dandekar, S. C., Patel, J. P., Tang, Z., Zumbo, P., Li, S., Zavadil, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2558 · Cited by 296 · see citing works

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Li, B., Brady, S. W., Ma, X., Shen, S., Zhang, Y., Li, Y., Szlachta, K. A., Dong, L., Liu, Y., Yang, F., et al. (2019) · Blood · doi:10.1182/blood.2019002220 · Cited by 289 · see citing works

Mammalian HECT ubiquitin-protein ligases: Biological and pathophysiological aspects

Scheffner, M., & Kumar, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.024 · Cited by 285 · see citing works

Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model

Schrörs, B., Boegel, S., Albrecht, C. H., Bukur, T., Bukur, V., Holtsträter, C., Ritzel, C., Manninen, K., Tadmor, A. D., Vormehr, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01195 · Cited by 207 · see citing works

Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia

Mar, B. G., Bullinger, L., McLean, K. M., Grauman, P. V., Harris, M. H., Stevenson, K. E., Neuberg, D. S., Sinha, A. U., Sallan, S. E., Silverman, L. B., et al. (2014) · Nature Communications · doi:10.1038/ncomms4469 · Cited by 198 · see citing works

Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer

Cheng, Q., Chang, J. T., Geradts, J., Neckers, L. Μ., Haystead, T., Spector, N. L., & Lyerly, H. K. (2012) · Breast Cancer Research · doi:10.1186/bcr3168 · Cited by 185 · see citing works

Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer

Carethers, J. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i31.9253 · Cited by 176 · see citing works

A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity

Pettitt, S. J., Rehman, F. L., Bajrami, I., Brough, R., Wållberg, F., Kozarewa, I., Fenwick, K., Assiotis, I., Chen, L., Campbell, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061520 · Cited by 173 · see citing works

E3 ubiquitin ligases in cancer and implications for therapies

Wang, D., Ma, L., Wang, B., Liu, J., & Wei, W. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9703-z · Cited by 173 · see citing works

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A. J., Lin, T.-N., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00167-4 · Cited by 153 · see citing works

Regulation and cellular functions of class II phosphoinositide 3-kinases

Falasca, M., & Maffucci, T. (2012) · Biochemical Journal · doi:10.1042/bj20120008 · Cited by 151 · see citing works

Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Bernt, K. M., & Hunger, S. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00054 · Cited by 154 · see citing works

SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia

Mar, B. G., Chu, S. H., Kahn, J. D., Krivtsov, A. V., Koche, R. P., Castellano, C. A., Kotlier, J. L., Zon, R. L., McConkey, M. E., Chabon, J. R., et al. (2017) · Blood · doi:10.1182/blood-2017-03-775569 · Cited by 139 · see citing works

Staphylococcus aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers

Ramirez, H. A., Pastar, I., Jozic, I., Stojadinović, O., Stone, R. C., Ojeh, N. O., Gil, J., Davis, S. C., Kirsner, R. S., & Tomic‐Canic, M. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.11.038 · Cited by 134 · see citing works

Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia

Will, B., Vogler, T. O., Narayanagari, S., Bartholdy, B., Todorova, T. I., da Silva Ferreira, M., Chen, J., Yu, Y., Mayer, J., Barreyro, L., et al. (2015) · Nature Medicine · doi:10.1038/nm.3936 · Cited by 127 · see citing works

HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma

Li, H., Li, J., Chen, L., Qi, S., Yu, S., Weng, Z., Hu, Z., Zhou, Q., Xin, Z., Shi, L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3791 · Cited by 126 · see citing works

Functional and pathological relevance of HERC family proteins: a decade later

Sánchez‐Tena, S., Cubillos‐Rojas, M., Schneider, T., & Rosa, J. L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2139-8 · Cited by 118 · see citing works

Differentiating Lynch-Like From Lynch Syndrome

Carethers, J. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.041 · Cited by 116 · see citing works

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

Landré, V., Rotblat, B., Melino, S., Bernassola, F., & Melino, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2431 · Cited by 105 · see citing works

Targeting PI3K in Cancer: Any Good News?

Martini, M., Ciraolo, E., Gulluni, F., & Hirsch, E. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00108 · Cited by 101 · see citing works

DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells

Chung, J., Maruvka, Y. E., Sudhaman, S., Kelly, J., Haradhvala, N. J., Bianchi, V., Edwards, M., Forster, V. J., Nunes, N. M., Galati, M. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0790 · Cited by 85 · see citing works

Mutational signatures are markers of drug sensitivity of cancer cells

Levatić, J., Salvadores, M., Fuster‐Tormo, F., & Supek, F. (2022) · Nature Communications · doi:10.1038/s41467-022-30582-3 · Cited by 77 · see citing works

Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability

Shlush, L. I., Chapal-Ilani, N., Adar, R., Pery, N., Maruvka, Y. E., Spiro, A., Shouval, R., Rowe, J. M., Tzukerman, M., Bercovich, D., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388629 · Cited by 72 · see citing works

A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

Cheng, Q., Chang, J. T., Gwin, W. R., Zhu, J., Ambs, S., Geradts, J., & Lyerly, H. K. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0407-9 · Cited by 71 · see citing works

The role of DNA mismatch repair in immunotherapy of human cancer

He, Y., Zhang, L., Zhou, R., Wang, Y., & Chen, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71714 · Cited by 67 · see citing works

Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies

Gaymes, T. J., Mohamedali, A. M., Patterson, M., Matto, N., Smith, A., Kulasekararaj, A. G., Chelliah, R., Curtin, N. J., Farzaneh, F., Shall, S., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.079251 · Cited by 64 · see citing works

Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma

Shia, J. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.018 · Cited by 59 · see citing works

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia

Evensen, N. A., Madhusoodhan, P. P., Meyer, J., Saliba, J., Chowdhury, A., Araten, D. J., Nersting, J., Bhatla, T., Vincent, T. L., Teachey, D. T., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.176362 · Cited by 55 · see citing works

c-Myc phosphorylation by PKCζ represses prostate tumorigenesis

Kim, J. Y., Valencia, T., Abu‐Baker, S., Linares, J., Lee, S. J., Yajima, T., Chen, J., Eroshkin, A. M., Castilla, E. A., Brill, L. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221799110 · Cited by 56 · see citing works

Maintenance therapy of childhood acute lymphoblastic leukemia revisited—Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?

Schmiegelow, K., Nersting, J., Nielsen, S. N., Heyman, M. M., Wesenberg, F., Kristinsson, J., Vettenranta, K. K., Schrøeder, H., Weinshilboum, R. M., Jensen, K. L., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26139 · Cited by 55 · see citing works

Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy

Nishii, R., Moriyama, T., Janke, L. J., Yang, W., Suiter, C. C., Lin, T.-N., Li, L., Kihira, K., Toyoda, H., Hofmann, U., et al. (2018) · Blood · doi:10.1182/blood-2017-11-815506 · Cited by 57 · see citing works

Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse

Yang, F., Brady, S. W., Tang, C. S., Sun, H., Du, L., Barz, M., Ma, X., Chen, Y., Fang, H., Li, X., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00230-8 · Cited by 54 · see citing works

Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments

Iacobucci, I., Papayannidis, C., Lonetti, A., Ferrari, A., Baccarani, M., & Martinelli, G. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0122-5 · Cited by 53 · see citing works

Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers

Lønning, P. E., & Knappskog, S. (2013) · Oncogene · doi:10.1038/onc.2013.48 · Cited by 53 · see citing works

HERC Ubiquitin Ligases in Cancer

Sala-Gaston, J., Martinez-Martinez, A., Pedrazza, L., Lorenzo‐Martín, L. F., Caloto, R., Bustelo, X. R., Ventura, F., & Rosa, J. L. (2020) · Cancers · doi:10.3390/cancers12061653 · Cited by 50 · see citing works

Helicobacter pyloriand the molecular pathogenesis of intestinal-type gastric carcinoma

Hanada, K., & Graham, D. Y. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.911092 · Cited by 49 · see citing works

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia

Pierro, J., Hogan, L. E., Bhatla, T., & Carroll, W. L. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1347507 · Cited by 44 · see citing works

HERCing: Structural and Functional Relevance of the Large HERC Ubiquitin Ligases

García‐Cano, J., Martinez-Martinez, A., Sala-Gaston, J., Pedrazza, L., & Rosa, J. L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01014 · Cited by 43 · see citing works

The Determinants of Head and Neck Cancer: Unmasking the PI3K Pathway Mutations

Squarize, F. S. G. C. H. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s5-003 · Cited by 42 · see citing works

Class II Phosphoinositide 3-Kinases as Novel Drug Targets

Falasca, M., Hamilton, J. R., Selvadurai, M. V., Sundaram, K., Adamska, A., & Thompson, P. E. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00963 · Cited by 41 · see citing works

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2

Liu, P., Ma, D., Wang, P., Pan, C., Fang, Q., & Wang, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03331-x · Cited by 43 · see citing works

DNA repair and the contribution to chemotherapy resistance

Nesic, K., Parker, P., Swisher, E. M., & Krais, J. J. (2025) · Genome Medicine · doi:10.1186/s13073-025-01488-8 · Cited by 50 · see citing works

PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia.

Li, J.-P., Hlavka-Zhang, J., Shrimp, J. H., Piper, C., Dupéré-Richer, D., Roth, J. S., Jing, D.-H., Roman, H. L. C., Troche, C., Swaroop, A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1771 · Cited by 33 · see citing works

The impact of rare germline variants on human somatic mutation processes

Vali-Pour, M., Park, S., Espinosa‐Carrasco, J., Ortiz-Martínez, D., Lehner, B., & Supek, F. (2022) · Nature Communications · doi:10.1038/s41467-022-31483-1 · Cited by 38 · see citing works

The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation

Schneider, T., Martinez-Martinez, A., Cubillos‐Rojas, M., Bartrons, R., Ventura, F., & Rosa, J. L. (2018) · Oncotarget · doi:10.18632/oncotarget.25847 · Cited by 37 · see citing works

DNA repair pathways as guardians of the genome: Therapeutic potential and possible prognostic role in hematologic neoplasms

Rahimian, E., Amini, A., Alikarami‬, F., Pezeshki, S. M. S., Saki, N., & Safa, M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102951 · Cited by 35 · see citing works

The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination

Cubillos‐Rojas, M., Schneider, T., Hadjebi, O., Pedrazza, L., de Oliveira, J. R., Vives, F. L., Guénet, J., Duran, J., de Anta, J. M., Alcántara, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11270 · Cited by 32 · see citing works

Approaches to diagnose DNA mismatch repair gene defects in cancer

Peña-Dı́az, J., & Rasmussen, L. J. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.11.022 · Cited by 32 · see citing works

Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells

Xie, X., Zhao, H., Hu, Y., & GU, X.-D. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1932 · Cited by 31 · see citing works

Loss of Heterozygosity Is Present in SEC63 Germline Carriers with Polycystic Liver Disease

Janssen, M. J., Salomon, J., Morsche, R. H. M. T., & Drenth, J. P. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050324 · Cited by 31 · see citing works

A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1

Xu, Y., Ji, K., Wu, M., Yao, K., Yao, K.-T., & Xu, Y. (2019) · Protein & Cell · doi:10.1007/s13238-019-0607-2 · Cited by 27 · see citing works

Mechanisms of NT5C2 -Mediated Thiopurine Resistance in Acute Lymphoblastic Leukemia

Moriyama, T., Liu, S., Li, J., Meyer, J., Zhao, X., Yang, W., Shao, Y., Heath, R. J., Hnı́zda, A., Carroll, W. L., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1112 · Cited by 27 · see citing works

Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy

Mas-Ponte, D., McCullough, M., & Supek, F. (2022) · Clinical Science · doi:10.1042/cs20210682 · Cited by 23 · see citing works

A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors

Cheng, Q., Li, X., Acharya, C. R., Hyslop, T., & Sosa, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15128 · Cited by 23 · see citing works

Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review

Calderón‐Montaño, J. M., Burgos‐Morón, E., Orta, M. L., & López‐Lázaro, M. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140601203816 · Cited by 22 · see citing works

Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification

Fu, S., Liu, X., Luo, M., Xie, K., Nice, E. C., Zhang, H., & Huang, C. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1299006 · Cited by 21 · see citing works

Convergent network effects along the axis of gene expression during prostate cancer progression

Charmpi, K., Guo, T., Zhong, Q., Wagner, U., Sun, R., Toussaint, N. C., Fritz, C., Yuan, C., Chen, H., Rupp, N. J., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02188-9 · Cited by 21 · see citing works

A versatile microsatellite instability reporter system in human cells

Koole, W., Schäfer, H. S., Agami, R., van Haaften, G. W., & Tijsterman, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt615 · Cited by 20 · see citing works

Getting Lost in the Cell–Lysosomal Entrapment of Chemotherapeutics

Zhai, X., & Hiani, Y. E. (2020) · Cancers · doi:10.3390/cancers12123669 · Cited by 19 · see citing works

Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis

Held, M. A., Greenfest‐Allen, E., Jachimowicz, E., Stoeckert, C. J., Stokes, M. P., Wood, A. W., & Wojchowski, D. M. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.03.003 · Cited by 18 · see citing works

Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

Larsen, R., Hjalgrim, L. L., Grell, K., Kristensen, K., Pedersen, L. G., Brünner, E. D., Als-Nielsen, B. E. T., Schmiegelow, K., & Nersting, J. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04097-x · Cited by 16 · see citing works

DNA Repair and Resistance to Cancer Therapy

Antnio, S., Costa, B. A., Martins, C., Gromicho, M., Nuno, G., Patrcia, S., & Rueff, J. (2013) · InTech eBooks · doi:10.5772/53952 · Cited by 16 · see citing works

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

Kroeze, E., Weijers, D. D., Hagleitner, M. M., de Groot-Kruseman, H. A., Jongmans, M. C. J., Kuiper, R. P., Pieters, R., Meijerink, J. P. P., & Loeffen, J. L. C. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000668 · Cited by 16 · see citing works

HERC1 Regulates Breast Cancer Cells Migration and Invasion

Rossi, F. A., Roitberg, E. C. C., Steinberg, J. H. E., Joshi, M., Espinosa, J. M., & Rossi, M. (2020) · bioRxiv · doi:10.3390/cancers13061309 · Cited by 15 · see citing works

Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway.

Dong, L., Jiang, H.-Q., Kang, Z.-H., & Guan, M. (2023) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2023.117338 · Cited by 12 · see citing works

Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia

Teng, J.-Y., Yang, D., Tang, C. S., Fang, H., Sun, H., Xiang, Y.-N., Li, X., Yang, F., Xia, R., Fan, F., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01902-3 · Cited by 13 · see citing works

An Inducible, Isogenic Cancer Cell Line System for Targeting the State of Mismatch Repair Deficiency

Bailis, J. M., Gordon, M. L., Gurgel, J. L., Komor, A. C., Barton, J. K., & Kirsch, I. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078726 · Cited by 13 · see citing works

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

Kroeze, E., Weijers, D., Hagleitner, M. M., de Groot‐Kruseman, H. A., Jongmans, M. C. J., Kuiper, R. P., Pieters, R., Meijerink, J. P. P., Loeffen, J. L. C., Genetica, et al. (2022) · Utrecht University Repository (Utrecht University) · Cited by 12 · see citing works

The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation

Ali, M. S., Magnati, S., Panuzzo, C., Cilloni, D., Saglio, G. N., Pergolizzi, B., & Bracco, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020324 · Cited by 12 · see citing works

Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing

Ishida, H., Iguchi, A., Aoe, M., Takahashi, T., Tamefusa, K., Kanamitsu, K., Fujiwara, K., Washio, K., Matsubara, T., Tsukahara, H., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3554-8 · Cited by 13 · see citing works

Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis

Czaja, A. J. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15743 · Cited by 13 · see citing works

Differential mRNA and long noncoding RNA expression profiles in pediatric B-cell acute lymphoblastic leukemia patients

Xia, J., Wang, M., Zhu, Y., Bu, C., & Li, T. (2022) · BMC Pediatrics · doi:10.1186/s12887-021-03073-5 · Cited by 11 · see citing works

Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials

González‐Gil, C., Morgades, M., Lopes, T., Fuster‐Tormo, F., García-Chica, J., Zhao, R., Montesinos, P., Torrent, A., Díaz‐Beyá, M., Coll, R., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281196 · Cited by 11 · see citing works

Comparison of whole exome sequencing in circulating tumor cells of primitive and metastatic nasopharyngeal carcinoma

Si, J., Huang, B., Lan, G., Zhang, B., Wei, J., Deng, Z.-X., Li, Y., Qin, Y., Li, B., Lu, Y., et al. (2020) · Translational Cancer Research · doi:10.21037/tcr-19-2899 · Cited by 10 · see citing works

PKCζ and PKMζ are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity

Hartsink-Segers, S. A., Beaudoin, J. J., Luijendijk, M. W. J., Exalto, C., Pieters, R., & den Boer, M. L. (2014) · Leukemia · doi:10.1038/leu.2014.210 · Cited by 10 · see citing works

Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia

Iacobucci, I., Lonetti, A., Papayannidis, C., & Martinelli, G. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990089 · Cited by 10 · see citing works

Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer

Yang, Q., Zhu, C., Zhang, Y., Wang, Y., Wang, Y., Zhu, L., Yang, X., Li, J., Nie, H., Jiang, S., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25506 · Cited by 10 · see citing works

The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner

Ali, M. S., Panuzzo, C., Calabrese, C., Maglione, A., Piazza, R., Cilloni, D., Saglio, G. N., Pergolizzi, B., & Bracco, E. (2021) · Cancers · doi:10.3390/cancers13020341 · Cited by 10 · see citing works

An Integrated Approach for RNA-seq Data Normalization

Yang, S., Mercante, D. E., Zhang, K., & Fang, Z. (2016) · Cancer Informatics · doi:10.4137/cin.s39781 · Cited by 9 · see citing works

The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN

Du, X., Sheng, J., Chen, Y., He, S., Yang, Y., Huang, Y., Fu, Y., Lie, L., Han, Z., Zhu, B., et al. (2023) · Science Signaling · doi:10.1126/scisignal.abm1756 · Cited by 9 · see citing works

Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis

Kind, M., Klukowska‐Rötzler, J., Berezowska, S., Arcaro, A., & Charles, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187308 · Cited by 9 · see citing works

Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy

Sun, L., Fan, G., Zhang, Z., Chang, D., Zhang, X., Zhang, T., Geng, J., Zhang, X., Lin, M., Chen, H., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115269 · Cited by 8 · see citing works

Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies

Delvecchio, V. S., Fierro, C., Giovannini, S., Melino, G., & Bernassola, F. (2021) · Discover Oncology · doi:10.1007/s12672-021-00435-4 · Cited by 8 · see citing works

Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations

Crisafulli, G. (2024) · Cancers · doi:10.3390/cancers16172956 · Cited by 7 · see citing works

TWEAK and TNFα, Both TNF Ligand Family Members and Multiple Sclerosis-Related Cytokines, Induce Distinct Gene Response in Human Brain Microvascular Endothelial Cells

Stephan, D., Roger, A., Aghzadi, J., Carmona, S., Picard, C., Dalès, J.-P., & Desplat‐Jégo, S. (2022) · Genes · doi:10.3390/genes13101714 · Cited by 7 · see citing works

Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells

Qing, Y., & Gerson, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182175 · Cited by 7 · see citing works

Therapeutic 6-thio-deoxyguanosine inhibits telomere elongation in cancer cells by inducing a non-productive stalled telomerase complex

Sanford, S. L., Badstübner, M., Gerber, M. H., Mannherz, W. P., Lampl, N. M., Dannenberg, R. L., Hinchie, A. M., Schaich, M. A., Myong, S., Hedglin, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66534-w · Cited by 10 · see citing works

Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion and altered sensory function in mice

Diouf, B., Devaraju, P., Janke, L. J., Fan, Y., Frase, S., Eddins, D. M., Peters, J. L., Kim, J., Pei, D., Cheng, C., et al. (2016) · Scientific Reports · doi:10.1038/srep30757 · Cited by 6 · see citing works

Dynamics of leucocyte DNA thioguanine nucleotide levels during maintenance therapy of childhood acute lymphoblastic leukemia

Larsen, R., Hjalgrim, L. L., Degn, M., Nersting, J., Als-Nielsen, B. E. T., Grell, K., & Schmiegelow, K. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04219-5 · Cited by 6 · see citing works

Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours

Boller, D., Doepfner, K. T., Laurentiis, A. D., Stücklin, A. G., MARINOV, M., Shalaby, T., Depledge, P., ROBSON, A., Saghir, N., Hayakawa, M., et al. (2022) · Anticancer Research · doi:10.21873/anticanres.15812 · Cited by 6 · see citing works

Childhood Leukemia

Campana, D., & Pui, C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00096-5 · Cited by 6 · see citing works

Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2

Arlow, T., Scott, K. A., Wagenseller, A. G., & Gammie, A. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215510110 · Cited by 43 · see citing works

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

de Wind, N., Dekker, M., Berns, A. J. M., Radman, M., & Riele, H. T. (1995) · Cell · doi:10.1016/0092-8674(95)90319-4 · Cited by 780 · see citing works

Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level

Claij, N., & Riele, H. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205395 · Cited by 55 · see citing works

MOLECULAR BIOLOGY

Arlow, T., Gammie, A. A., & Rose, M. D. (2012)

The roles of MLH1 and MSH2 in growth and drug resistance in human colorectal cancer cells

Barber, A. C. (2012) · The Atrium (University of Guelph)